Publication
Intermittent enzalutamide in recurrent prostate cancer: testosterone kinetics and related toxicity.
Jennifer L Marte, Amy Hankin, Monique Williams, James L Gulley, Fatima Karzai, Marijo Bilusic, Lisa Cordes, William D Figg, Ravi A Madan, Melissa L Abel
- Source
- PubMed
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260915-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
OBJECTIVES: To determine the relationship between gynaecomastia and testosterone levels in patients with biochemically recurrent prostate cancer treated with androgen receptor pathway inhibitor (ARPI) monotherapy. PATIENTS AND METHODS: This analysis evaluates changes in serum testosterone and the…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Prostate Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available